Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.04%
#2 Pons Pons +38.47%
#3 Starpower Starpower +30.38%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.10%
#5 TENDIES TENDIES +24.03%
#6 Mubarak Mubarak +23.85%
#7 StonkBroker StonkBroker +21.99%
#8 SkyAI SkyAI +20.90%
#9 Decred Decred +19.75%
#10 PondCoin PondCoin +17.74%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Sofiva Genomics Co.,Ltd. Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd.

6615
Rank in Stocks #29070
Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan,... Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan, offers a comprehensive range of genetic testing services to both domestic and international clients. The company's diverse diagnostic solutions are designed to support expectant parents, individuals with inherited conditions, and their families. Their extensive prenatal diagnostics include screenings for conditions such as thalassemia carrier status, various microdeletion syndromes, single-gene abnormalities, common chromosomal anomalies, and specific skeletal dysplasia mutations. They also provide multi-gene panel testing for inherited diseases, folate metabolism genetic analysis, carrier screening for spinal muscular atrophy (SMA) and Fragile X syndrome, congenital infection detection, preeclampsia risk assessment, maternal serum screening for Down syndrome, and karyotyping. Within the oncology sector, Sofiva Genomics delivers advanced cancer screenings, dynamic monitoring of tumor activity, and genetic evaluations for hereditary cancer predisposition. This includes specialized panels for women's cancers (breast, colon, ovarian, and endometrial), alongside human papillomavirus (HPV) screening. Furthermore, the company conducts genetic testing for rare diseases and provides specialized reproductive services such as preimplantation genetic diagnosis (PGD) and next-generation sequencing (NGS)-based preimplantation genetic screening (PGS). For newborns, their services encompass comprehensive "baby scans," screenings for hereditary sensorineural hearing loss, congenital central hypoventilation syndrome (CCHS), congenital cytomegalovirus (CMV) infection, and genetic risk assessment for atopic dermatitis. Beyond these specialized offerings, Sofiva Genomics also performs biochemical and chromosomal analyses, complemented by valuable advisory and support services for its clientele.
Share Price
$1.07
Market Cap
$23.11M
Change (1 day)
0.00%
Change (1 year)
4.66%
Country
TW
Trade Sofiva Genomics Co.,Ltd. (6615)

Category

Healthcare
Revenue for Sofiva Genomics Co.,Ltd. (6615)
Revenue in Aug 2026 TTM: 0
According to Sofiva Genomics Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sofiva Genomics Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US